| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2023/10/04 | 20 : 30 | GlobeNewswire Inc. | BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/10/04 | 20 : 30 | GlobeNewswire Inc. | Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/08/16 | 21 : 30 | GlobeNewswire Inc. | Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/07/17 | 21 : 00 | GlobeNewswire Inc. | Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/06/14 | 19 : 09 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/06/14 | 19 : 06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/06/13 | 21 : 30 | GlobeNewswire Inc. | Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/05/31 | 05 : 04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/05/20 | 05 : 50 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/05/20 | 05 : 05 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/05/16 | 05 : 29 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/05/15 | 19 : 38 | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/05/13 | 05 : 17 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/05/03 | 21 : 47 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/05/03 | 21 : 44 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/05/03 | 21 : 30 | GlobeNewswire Inc. | Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/04/28 | 05 : 35 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/02/15 | 05 : 39 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2023/02/03 | 00 : 10 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2022/11/04 | 06 : 10 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2022/10/12 | 05 : 07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2022/08/11 | 05 : 33 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2022/05/13 | 05 : 55 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2022/03/12 | 06 : 05 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2022/02/10 | 04 : 14 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2021/12/06 | 22 : 00 | GlobeNewswire Inc. | BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2021/12/03 | 10 : 55 | GlobeNewswire Inc. | BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2020/02/03 | 22 : 30 | GlobeNewswire Inc. | Option Care Health Completes Reverse Stock Split and Ticker Symbol Change | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2019/12/27 | 06 : 24 | GlobeNewswire Inc. | RLH Corporation Appoints R. Carter Pate as Chairman | NASDAQ:BIOS | BioPlus Acquisition Corporation |
| 2019/12/18 | 23 : 22 | GlobeNewswire Inc. | Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare Conference | NASDAQ:BIOS | BioPlus Acquisition Corporation |